Research Article

Integrating Network Pharmacology and Experimental Validation to Elucidate the Mechanism of Yiqi Yangyin Decoction in Suppressing Non-Small-Cell Lung Cancer

Figure 8

EGFR-PI3K-AKT signaling is responsible for the anticancer activity of YYD in NSCLC. Cells were treated with 250 μg/ml YYD, 100 μM NSC228155, or simultaneously treated with 250 μg/ml YYD and 100 μM NSC228155. (a) Western blot assays were performed to examine the related protein expression. (b–d) Cell proliferation capability was determined. (e, f) Cell cycle distribution and apoptosis were examined. , , and versus the control or YYD group.
(a)
(b)
(c)
(d)
(e)
(f)